Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falzoni, S.
Right arrow Articles by Di Virgilio, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falzoni, S.
Right arrow Articles by Di Virgilio, F.

Vol. 11, Issue 9, 3169-3176, September 2000

P2X7 Receptor and Polykarion Formation

Simonetta Falzoni,* Paola Chiozzi,* Davide Ferrari,* Gary Buell,dagger and Francesco Di Virgilio*Dagger

 *Department of Experimental and Diagnostic Medicine, Section of General Pathology, and  Dagger Biotechnology Center, University of Ferrara, Ferrara, Italy; and  dagger Serono Pharmaceutical Research Institute, Geneva, Switzerland

Cell fusion is a central phenomenon during the immune response that leads to formation of large elements called multinucleated giant cells (MGCs) of common occurrence at sites of granulomatous inflammation. We have previously reported on the involvement in this event of a novel receptor expressed to high level by mononuclear phagocytes, the purinergic P2X7 receptor. Herein, we show that blockade of this receptor by a specific monoclonal antibody prevents fusion in vitro. In contrast, cell fusion is stimulated by addition of enzymes that destroy extracellular ATP (i.e., apyrase or hexokinase). Experiments performed with phagocytes selected for high (P2X7 hyper) or low (P2X7 hypo) P2X7 expression show that fusion only occurs between P2X7 hyper/P2X7 hyper and not between P2X7 hyper/P2X7 hypo or P2X7 hypo/P2X7 hypo. During MGCs formation we detected activation of caspase 3, an enzyme that is powerfully stimulated by P2X7. Finally, we observed that during MGCs formation, the P2X7 receptor is preferentially localized at sites of cell-to-cell contact. These findings support the hypothesis originally put forward by our group that the P2X7 receptor participates in multinucleated giant cell formation.


Dagger Author correspondence to: E-mail address: fdv{at}dns.unife.it.


Molecular Biology of the Cell
Vol. 11, 3169-3176, September 2000
Copyright © 2000 by The American Society for Cell Biology



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. L. Gavala, Z. A. Pfeiffer, and P. J. Bertics
The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells
J. Leukoc. Biol., October 1, 2008; 84(4): 1159 - 1171.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Pizzirani, D. Ferrari, P. Chiozzi, E. Adinolfi, D. Sandona, E. Savaglio, and F. Di Virgilio
Stimulation of P2 receptors causes release of IL-1{beta}-loaded microvesicles from human dendritic cells
Blood, May 1, 2007; 109(9): 3856 - 3864.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Lemaire, S. Falzoni, N. Leduc, B. Zhang, P. Pellegatti, E. Adinolfi, P. Chiozzi, and F. Di Virgilio
Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells
J. Immunol., November 15, 2006; 177(10): 7257 - 7265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Auger, I. Motta, K. Benihoud, D. M. Ojcius, and J. M. Kanellopoulos
A Role for Mitogen-activated Protein KinaseErk1/2 Activation and Non-selective Pore Formation in P2X7 Receptor-mediated Thymocyte Death
J. Biol. Chem., July 29, 2005; 280(30): 28142 - 28151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Coutinho-Silva, L. Stahl, K.-K. Cheung, N. E. de Campos, C. de Oliveira Souza, D. M. Ojcius, and G. Burnstock
P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1024 - G1035.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. F. Hiken and T. H. Steinberg
ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C403 - C412.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Labasi, N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, and C. A. Gabel
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
J. Immunol., June 15, 2002; 168(12): 6436 - 6445.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Blood, February 1, 2001; 97(3): 587 - 600.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]